Treatment of excessive osteolyisis with indolinone compounds

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/55 (2006.01) A61K 31/40 (2006.01) A61K 31/403 (2006.01) A61K 31/535 (2006.01)

Patent

CA 2516786

Compounds of Formula I and Formula II, as described herein, are useful for treating excessive osteolysis, by inhibiting M-CSF mediated osteoclast development. The compounds also are useful for inhibiting phosphorylation of CSF1R, and for treating cancers that express CSF1R.

Tels qu'ils sont décrits ici, les composés représentés par les formules I et II sont utiles pour le traitement de l'ostéolyse excessive par inhibition du développement des ostéoclastes induits par M-CSF. Ces composés conviennent également pour inhiber la phosphorylation de CSF1R, et pour le traitement de cancers exprimant CSF1R.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of excessive osteolyisis with indolinone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of excessive osteolyisis with indolinone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of excessive osteolyisis with indolinone compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1454409

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.